Zap Surgical Systems Raises $36M to Scale Robotic Radiosurgery
Zap Surgical Systems raised $36M to scale deployment of its ZAP-X robotic radiosurgery platform for non-invasive brain tumor treatment.

The big picture: Zap Surgical Systems, a San Carlos, California-based company, has raised $36 million in financing led by Catalio Capital Management. The capital will be used to expand sales and production of its ZAP-X robotic radiosurgery platform, which provides non-invasive treatment for brain tumors and other neurological conditions.
Why it matters:
- Non-invasive treatment: The ZAP-X platform offers a precise, incision-free alternative to traditional brain surgery, potentially reducing patient recovery times and risks associated with open procedures.
- Global accessibility: By scaling production and deployment, Zap Surgical aims to make advanced radiosurgery more broadly accessible across academic medical centers, community hospitals, and physician practices worldwide.
- Cost-effective care: Intelligent robotics in healthcare can help address rising costs in developed nations and improve access to high-standard care in underserved markets, aligning with a broader trend towards more efficient medical solutions.
How it works:
- Stereotactic radiosurgery: The ZAP-X system uses highly focused radiation to target specific areas in the brain, delivering therapeutic doses without requiring a surgical incision.
- Gyroscopic Radiosurgery: This proprietary approach allows radiation to be delivered from multiple angles, enhancing precision and minimizing exposure to healthy surrounding tissue.
- Radiomodulation research: Zap Surgical is also exploring lower-dose targeted radiation for ‘radiomodulation’ to influence brain activity, with early pilot studies for severe depression and addiction underway, though these applications remain in early clinical stages.
The catch: While ZAP-X has achieved significant commercial traction with 50 systems shipped and nearly 10,000 patients treated, the market for advanced medical robotics is competitive. Expanding into new clinical applications like radiomodulation for psychiatric conditions will require extensive clinical validation and regulatory approvals, representing a long-term investment with uncertain timelines compared to its established radiosurgery business.
Key Facts
- Company: Zap Surgical Systems
- Amount: $36M
- Investors: Catalio Capital Management (lead), Baheal
- Founder: John R. Adler
- Announced: 2026-10-19
- Sector: Robotic Radiosurgery
- Headquarters: San Carlos, California, US
AIPressRoom Weekly
Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.